NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States,
AVTR vs. PGNY: Which Stock Is the Better Value Option?
These two healthcare companies have bright futures -- and right now, two-digit price tags.

Investors see growth opportunity in Femtech

08:42am, Monday, 21'st Mar 2022
Funding for so-called Femtech has more than tripled since 2015. Early stage investors see growth opportunities in companies like breast cancer imaging start-up Clairity, which are looking to close the
OCDX vs. PGNY: Which Stock Is the Better Value Option?

Progyny, Inc. to Present at the Barclays Global Healthcare Conference

02:30pm, Thursday, 10'th Mar 2022 GlobeNewswire
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference on Tuesday, March 15, 2022 at 3:50 P.M. Eastern Time.
NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States,
Harbor Investment Advisory LLC lifted its holdings in shares of Progyny, Inc. by 89.3% during the fourth quarter, according to the company in its most recent Form 13F filing…

Empire State Realty Trust Signs Progyny at 1359 Broadway

05:47pm, Wednesday, 02'nd Mar 2022 The Real Deal
Fertility benefits firm Progyny is adding to a sublease it already had at the Garment District building.
Progyny, Inc. (PGNY) CEO Pete Anevski on Q4 2021 Results - Earnings Call Transcript

Progyny, Inc. Announces Fourth Quarter and Full Year 2021 Results

09:05pm, Monday, 28'th Feb 2022 GlobeNewswire
Issues Guidance for 2022, Reflecting 50% Revenue Growth at Midpoint of the Range Reports Full Year Revenue of $500.6 Million, Reflecting 45% Growth Reports Fourth Quarter Revenue of $127.6 Million, Reflecting 27% Growth

Progyny (PGNY) Surpasses Q4 Earnings Estimates

07:53pm, Monday, 28'th Feb 2022
Progyny (PGNY) delivered earnings and revenue surprises of 275% and 6.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Progyny Q4 2021 Earnings Preview (NASDAQ:PGNY)

10:35pm, Sunday, 27'th Feb 2022 Seeking Alpha
Progyny (NASDAQ:PGNY) is scheduled to announce Q4 earnings results on Monday, February 28th, after market close.The consensus EPS Estimate is $0.04 (-42.9% Y/Y) and the consensus…
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period and full year ended December 31, 2021 after the close of the market on Monday, February 28, 2022.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE